PRP Platelet Rich Plasma Therapy at Chughtai Lab

PRP (Platelets Rich Plasma) at Chughtai Lab

Platelet-Rich Plasma (PRP) therapy is an advanced, autologous biological treatment that harnesses the body's natural healing mechanisms to accelerate tissue repair, reduce inflammation, and promote cellular regeneration. PRP is produced by concentrating platelets obtained from the patient's own blood. Platelets are highly specialized blood cells containing alpha-granules, which store and release a vast array of essential growth factors and bioactive proteins. These include Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-Beta (TGF-β), Vascular Endothelial Growth Factor (VEGF), and Epidermal Growth Factor (EGF). When introduced to damaged tissues, these growth factors stimulate cell migration, proliferation, angiogenesis, and extracellular matrix synthesis, facilitating rapid and structured healing.

At Chughtai Lab, particularly at specialized facilities such as the National Hospital branch in Lahore, Pakistan, PRP preparation is conducted under strict, state-of-the-art laboratory protocols. The procedure utilizes advanced closed-system centrifugation technology to isolate a highly concentrated platelet fraction while maintaining absolute sterility. This autologous approach virtually eliminates the risk of immunological reactions or cross-contamination, making it an exceptionally safe and biologically compatible therapeutic option. PRP therapy has gained significant clinical value across multiple medical specialties, including orthopedics, sports medicine, dermatology, and plastic surgery, providing a minimally invasive alternative to surgical interventions.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the highest quality of platelet yield and to minimize potential complications during the blood draw and subsequent administration. Patients undergoing PRP preparation at Chughtai Lab are advised to adhere to the following guidelines:

• Hydration: Drink plenty of water (at least 1 to 2 liters) in the 24 hours leading up to the procedure to facilitate venipuncture and optimize plasma volume.
• Medication Restrictions: Discontinue the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, naproxen, and aspirin for at least 7 to 10 days prior to the procedure, as these medications inhibit platelet function. Always consult your prescribing physician before altering any medication regimen.
• Anticoagulants: Discuss the management of blood thinners or antiplatelet medications with your physician, as these may need to be temporarily paused under strict medical supervision.
• Dietary Guidelines: Eat a light, healthy meal before the appointment. Avoid high-fat or greasy foods, which can cause lipemia (excess fat in the blood) and interfere with the centrifugation process.
• Avoid Toxins: Refrain from consuming alcohol and smoking for at least 48 hours before the procedure, as toxins can negatively impact platelet viability and overall healing capacity.

During the Procedure

The PRP preparation process at Chughtai Lab is a highly controlled, multi-step procedure designed to maximize patient comfort and ensure clinical precision:

• Venipuncture: A small volume of autologous blood (typically 10 to 30 mL, depending on the treatment area) is drawn from a vein in the patient's arm using a sterile, single-use butterfly needle and specialized collection tubes containing an anticoagulant.
• Centrifugation: The collected blood is immediately placed into a calibrated, high-precision centrifuge. Chughtai Lab utilizes advanced double-spin protocols to separate the blood components based on their specific gravity. The first spin separates red blood cells from the plasma, while the second spin concentrates the platelets into a distinct layer.
• Separation and Extraction: Under sterile laminar flow hoods, the laboratory specialist carefully extracts the platelet-rich fraction, separating it from the platelet-poor plasma (PPP) and the red blood cell pellet. This ensures a highly concentrated, pure PRP aliquot.
• Safety and Sterility: The entire process is conducted using closed-system kits to prevent any exposure to environmental contaminants, ensuring the final injectable product is completely sterile.
• Duration: The entire laboratory preparation process typically takes between 30 to 45 minutes, allowing for rapid, same-day clinical application.

When is a PRP (Platelets Rich Plasma) Performed?

Androgenetic Alopecia and Hair Thinning

PRP therapy is widely indicated for patients experiencing androgenetic alopecia (pattern hair loss) and telogen effluvium. When injected into the scalp, the concentrated growth factors in PRP stimulate the dermal papilla cells, prolong the anagen (growth) phase of the hair cycle, and reverse hair follicle miniaturization. Dermatologists and trichologists request this preparation to improve hair density, increase shaft thickness, and promote active hair regrowth in areas of thinning.

Osteoarthritis of the Knee and Joints

Physicians frequently prescribe PRP injections for patients suffering from mild-to-moderate osteoarthritis, particularly of the knee joint. The bioactive proteins in PRP help modulate the intra-articular inflammatory environment, inhibit chondrocyte apoptosis, and stimulate the synthesis of hyaluronic acid and type II collagen. This therapeutic approach assists in reducing joint pain, alleviating stiffness, and improving overall physical mobility, delaying the need for invasive joint replacement surgeries.

Chronic Tendon Injuries and Tendinopathy

Chronic tendinopathies, such as lateral epicondylitis (tennis elbow), plantar fasciitis, Achilles tendonitis, and rotator cuff tendinopathy, often exhibit poor intrinsic healing due to limited vascularity. PRP is utilized to deliver a high concentration of growth factors directly to the degenerated tendon tissue. This initiates a robust healing cascade, promotes tenocyte proliferation, stimulates collagen deposition, and accelerates the remodeling of disorganized tendon fibers.

Aesthetic Skin Rejuvenation

In aesthetic medicine, PRP is highly sought after for facial rejuvenation, often referred to as the “vampire facial” when combined with microneedling. The application of PRP stimulates dermal fibroblasts to produce new collagen and elastin fibers, improving skin texture, reducing fine lines, minimizing acne scars, and enhancing overall skin tone. Clinicians utilize this natural therapy to achieve tissue regeneration without the risk of foreign-body reactions.

Chronic Wound Healing and Ulcers

For patients presenting with non-healing diabetic foot ulcers, venous stasis ulcers, or pressure sores, PRP provides a biological scaffold rich in healing factors. It is applied topically or injected around the wound margins to stimulate angiogenesis (new blood vessel formation), recruit inflammatory cells to clear debris, and accelerate epithelialization, thereby promoting the closure of chronic, complex wounds.

What Does PRP (Platelets Rich Plasma) Detect or Evaluate?

While PRP is primarily a therapeutic preparation rather than a diagnostic test, the laboratory processing of PRP involves the evaluation of several critical biological parameters to ensure its safety, quality, and therapeutic efficacy. At Chughtai Lab, the following clinical and quality metrics are evaluated during the preparation and screening process:

• Baseline Systemic Platelet Count: Evaluates the patient's baseline platelet levels to ensure they are sufficient for effective concentration.
• Target Platelet Concentration Factor: Verifies that the centrifugation process has successfully concentrated platelets to at least 3 to 6 times the baseline systemic levels.
• Leukocyte Concentration: Determines whether the preparation is Leukocyte-Rich (LR-PRP) or Leukocyte-Poor (LP-PRP), which influences its clinical application (e.g., LP-PRP is preferred for intra-articular injections to minimize inflammation).
• Erythrocyte (RBC) Contamination: Assesses and minimizes the presence of red blood cells in the final concentrate, as excess RBCs can cause localized tissue irritation.
• Sterility Assessment: Ensures the entire closed-system processing maintains absolute sterility, preventing bacterial or fungal contamination.
• pH Level of the Concentrate: Monitors the pH of the prepared plasma to ensure it remains within a physiological range, reducing discomfort upon injection.
• Absence of Hemolysis: Confirms that the red blood cells have not ruptured during centrifugation, which could release harmful free hemoglobin.
• Platelet Membrane Integrity: Evaluates the physical state of the platelets to ensure they remain intact and functional prior to activation.
• Fibrinogen Concentration: Assesses the presence of fibrinogen, which forms the fibrin scaffold necessary for localized growth factor release.
• Anticoagulant Residue Levels: Monitors and controls the concentration of Acid Citrate Dextrose-A (ACD-A) to prevent tissue toxicity.
• Total Aliquot Volume: Measures the precise volume of the final PRP yield to match the clinical requirements of the target treatment site.
• Platelet Activation Status: Ensures platelets remain in a resting state during processing, ready to activate and release growth factors upon tissue contact.
• Hematocrit Level: Evaluates the proportion of red blood cells in the final concentrate to maintain optimal purity.
• Presence of Platelet Clumps: Verifies the absence of premature micro-clots that could interfere with smooth clinical administration.
• PDGF Concentration (Research/Specialized): Evaluates the levels of Platelet-Derived Growth Factor, crucial for cell replication and collagen synthesis.
• TGF-β Concentration (Research/Specialized): Assesses Transforming Growth Factor-Beta levels, which regulate extracellular matrix deposition.
• VEGF Concentration (Research/Specialized): Measures Vascular Endothelial Growth Factor, the primary driver of therapeutic angiogenesis.
• EGF Concentration (Research/Specialized): Evaluates Epidermal Growth Factor levels, which promote epithelial cell regeneration.
• FGF Concentration (Research/Specialized): Assesses Fibroblast Growth Factor, essential for tissue remodeling and repair.
• Processing Temperature Integrity: Monitors that centrifugation is conducted at controlled room temperature (20-22°C) to preserve platelet viability.
• Patient Eligibility Screening: Evaluates the patient's medical history to rule out absolute contraindications, such as critical thrombocytopenia, hemodynamic instability, or active systemic infections.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, efficient, and highly professional diagnostic and therapeutic processing services. Because platelet viability decreases over time once blood is drawn, the PRP preparation process is treated with high clinical priority. The extraction, double-spin centrifugation, quality verification, and sterile packaging of the PRP concentrate are completed within 1 to 2 hours of the initial blood draw.

Patients and referring physicians can access quality control reports and baseline hematology results online through the Chughtai Lab patient portal or the dedicated mobile application. Real-time SMS notifications are sent as soon as the sterile preparation is ready for clinical administration, ensuring seamless coordination between the laboratory and the treating specialist at the National Hospital or other clinical facilities.

PRP Preparation Findings Overview

The following table outlines the key biological parameters evaluated during the quality control and preparation of Platelet-Rich Plasma at Chughtai Lab:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Baseline Platelet Count	150,000 – 450,000 /µL	Thrombocytopenia (<150,000 /µL) or Thrombocytosis (>450,000 /µL) affecting final yield.
Platelet Concentration Factor	3.0x to 6.0x baseline concentration	Suboptimal concentration (<3.0x baseline) resulting in reduced therapeutic efficacy.
Leukocyte (WBC) Content	Controlled (Low in LP-PRP; High in LR-PRP)	Excessive neutrophils in LP-PRP, potentially causing unwanted post-injection inflammation.
Erythrocyte (RBC) Contamination	Minimal to undetectable (<1% hematocrit)	High RBC contamination, leading to localized tissue pain and oxidative stress.
Sterility Culture	No bacterial or fungal growth detected	Presence of bacterial or fungal pathogens, indicating contamination during processing.
pH of PRP Concentrate	7.0 – 7.5 (Physiological range)	Acidic pH (<7.0), which can cause significant pain and burning upon tissue injection.
Fibrinogen Levels	200 – 400 mg/dL	Deficient fibrinogen levels, leading to poor fibrin scaffold formation at the target site.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for PRP?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists specializing in transfusion medicine and cellular therapies.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the blood collection and preparation process.
• Quality Diagnostic Services: Chughtai Lab adheres to international standards of quality control, ensuring highly reliable and reproducible platelet concentration.
• Professional Reporting: Comprehensive documentation of baseline hematological parameters and processing metrics is provided for clinical transparency.
• Modern Diagnostic Approach: Utilizing state-of-the-art, closed-system centrifugation technology to guarantee the highest level of product purity and sterility.
• Comfortable Environment: Our dedicated collection centers, including the National Hospital branch in Lahore, offer a clean, sterile, and welcoming atmosphere.
• Convenient Location: Easily accessible facilities across major cities in Pakistan, ensuring prompt processing and delivery of therapeutic preparations.
• Commitment to Accurate Diagnosis: We employ rigorous quality assurance protocols to ensure that every PRP aliquot meets strict clinical efficacy guidelines.